Kieffer Tara Lynn
- SEC CIK
- 0001834835
In the past year, 1 open-market sale filing worth $30.0K and no purchases.
Current role at each company
- ENTA Enanta Pharmaceuticals IncChief Product Strategy Officeras of Feb 13, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $30.0K
- 1 filing
- Net
- −$30.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kieffer Tara Lynn as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 (view filing) | Dec 5 | Same day | Kieffer Tara LynnChief Product Strategy Officer | SSale | −2.11K | $14.23 | −$30.0K | −6.4%30.6K after | |
| Dec 10, 2024 (view filing) | Dec 6 | 4 days | Kieffer Tara LynnChief Product Strategy Officer | SSale | −2.28K | $8.06 | −$18.4K | −7.2%29.3K after | 10b5-1 |
| Jun 17, 2024 (view filing) | Jun 17 | Same day | Kieffer Tara LynnChief Product Strategy Officer | SSale | −7.27K | $12.33 | −$89.6K | −18.3%32.3K after | 10b5-1 |
| Dec 6, 2023 (view filing) | Dec 5 | 1 day | Kieffer Tara LynnSr. VP, New Prod. Strat. & Dev | SSale | −2.13K | $9.63 | −$20.5K | −5.4%37.3K after |